COPEGUS

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

RIBAVIRIN 200 MG

Mevcut itibaren:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATC kodu:

J05AB04

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

HOFFMANN LA ROCHE, SWITZERLAND

Terapötik grubu:

RIBAVIRIN

Terapötik endikasyonlar:

Copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum HCV-RNA, including patients with compensated cirrhosis . The combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable HIV , including patients with compensated cirrhosis . Copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.

Yetkilendirme tarihi:

2013-04-01